ArticleOncoTargets and therapy2019

Effect of the imatinib treatment regimen on the postoperative prognosis of patients with high-risk gastrointestinal stromal tumors.

Yan-Shu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.